91Âé¶¹ÌìÃÀ

ClinMicro Open speakers and panels

Our Work

Clin Micro Open (CMO) brings together laboratory and industry leaders to discuss current and potential issues affecting the future of diagnostic clinical microbiology. This event is a primary benefit of Corporate Council membership, providing networking and scientific exchange opportunities to enable these 2 groups to cultivate partnerships and positively impact patient care. CMO is held annually, typically in January/February.

What is Clin Micro Open?

Clin Micro Open (CMO) is a unique meeting where relationships are formed and technological advances are catalyzed. The meeting facilitates the open exchange of ideas among the medical microbiologists and 91Âé¶¹ÌìÃÀ Corporate Council representatives who attend the meeting.

Why Should You Attend CMO?

We believe that improvements in patient care begin with open dialogue between key stakeholders and decision makers. CMO allows attendees to truly engage with one another and leverage diverse views and expertise to address critical challenges and collaborative opportunities in the field of diagnostic microbiology.

Various images from CMO 2026

Laboratory directors and 91Âé¶¹ÌìÃÀ Corporate Council members discuss opportunities for partnership at Clin Micro Open.

Source: American Society for Microbiology


CMO 2026

91Âé¶¹ÌìÃÀ hosted its seventh CMO in Del Mar, Calif. The conference began on the evening of Feb. 4 and concluded late morning on Feb. 6. Approximately 50 attendees (a mixture of corporate council members and medical microbiologists) convened to hear insightful presentations and engage in meaningful discussions. Industry attendees were members of 91Âé¶¹ÌìÃÀ’s Corporate Council and identified by their company. Laboratory leaders were invited or selected based on their submitted application and willingness to actively participate.

Topics

The theme for CMO 2026 was diagnostic stewardship:

  • New or innovative methods used for diagnostic stewardship implementation at institutions.
  • Scaling and disseminating what works in diagnostic stewardship.
  • Success stories and lessons learned from navigating the financial factors related to diagnostic stewardship.
  • How the implementation of diagnostic stewardship positively or negatively impacts public health labs or public health activities. 

Participants presented keynote talks, followed by roundtable discussions, with the intent of formulating recommendations for future activities or collaborations. Incorporation of fun activities and games provided additional opportunities for attendees to share their knowledge and ideas.

Applicant Eligibility: 

91Âé¶¹ÌìÃÀ members who work full-time in a clinical or public health laboratory at the director level are elegible to apply. Applicants must work in the United States or Canada. Applicants who apply agree to present a 10-15 minute talk (if selected), serve as a scribe or moderator and actively participate in roundtable discussions during the event.

Applications for CMO 2026 are now closed. The application window for CMO 2027 will reopen in Sept. 2026.

Travel information:

91Âé¶¹ÌìÃÀ provides airfare (up to $600), 2 nights at the hotel, per diem for travel days and ground transportation for laboratory directors who were accepted or invited as speakers.


Who Can Attend?

Medical Microbiology Laboratory Directors

The application window for CMO 2027 will open in Sept. 2026. 91Âé¶¹ÌìÃÀ members who are full-time laboratory directors in the United States or Canada are eligible to apply.

Federal Agency and Public Health Decision Makers

Representatives from federal agencies are invited by the CMO Steering Committee to attend. 

91Âé¶¹ÌìÃÀ's Corporate Council Members

Our Corporate Council program offers companies a unique year-long relationship with 91Âé¶¹ÌìÃÀ and its members. Kingdom and Phylum members are automatically invited to attend CMO.

91Âé¶¹ÌìÃÀ's Corporate Council Program

Partnership between the public and private sectors is key to true advancement in the microbial sciences. 91Âé¶¹ÌìÃÀ’s Corporate Council bridges the gap—connecting leading companies in the field with 91Âé¶¹ÌìÃÀ members to find innovative solutions that will better serve our communities.

Join Today
 

Outcomes of Prior CMO Meetings

Updating breakpoints in the U.S.: CMO 2022 Summary

Proceedings of the Clinical Microbiology Open 2023

Proceedings of the Clinical Microbiology Open 2024


Testimonials

 

  • “The experience and caliber of people who attended the meeting was a dream come true, but most importantly, there was so much fun while learning.”
     
  • “Making some new connections with people I didn't know was the most valuable part of the meeting! The clinical outcomes topic and laboratory challenges seemed extremely relevant to us each individually as well as a diagnostic community. I also loved Shark Tank!”
     
  • “The clinical outcomes research was amazing; Really great to get the combined perspective of labs and industry in one place.”
     
  • "This is my favorite meeting!"
Various ClinMicro Open presentations and events

Participants at ClinMicro Open 2024

Source: American Society for Microbiology


Steering Committee Members

 

CMO was established in 2018 with the support of  91Âé¶¹ÌìÃÀ's Clinical and Public Health Microbiology Committee (CPHMC) and 91Âé¶¹ÌìÃÀ's Corporate Council.

The CMO Steering Committee is comprised of an equal number of medical laboratory directors and Corporate Council members who serve on the committee for up to 4 years. The committee is responsible for creating an agenda that will guide open dialogue and produce tangible outcomes from the meeting (e.g., papers/publications). The current members include:

 

  • Jennifer Dien Bard, Ph.D., D(ABMM), F(CCM), University of Southern California.
  • Allison Eberly, Ph.D., D(ABMM), Washington University School of Medicine in St. Louis.
  • Stephanie Ibbotson, MPH, Diasorin.
  • Rachael Liesman, Ph.D., D(ABMM), Medical College of Wisconsin.
  • Allison McMullen, Ph.D., D(ABMM), bioMérieux.
  • Ashley Nenninger, Ph.D., Hologic, Inc (Co-Chair).
  • David Peaper, M.D., Ph.D., D(ABMM), Yale University (Co-Chair).
  • Paul Rhodes, Ph.D., Next Gen Diagnostics.

Additional questions? Contact clinmicro@asmusa.org